NIH #R01CA161891
Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.
- Amount
- $300K–$400K
- Period
- 2011-09-21 → 2015-07-31
- PIs
- 2
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Cancer Immunotherapy and Biomarkers · Oncology
Compare more Oncology professors.
2 total · 0 active
NIH #R01CA161891
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #K23CA125205
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data may not be current
ORCID: 0000-0003-4737-1952